Cargando…
Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson’s disease
INTRODUCTION: After several years of brain-sensing technology development and proof-of-concept studies, adaptive deep brain stimulation (aDBS) is ready to better treat Parkinson’s disease (PD) using aDBS-capable implantable pulse generators (IPGs). New aDBS devices are capable of continuous sensing...
Autores principales: | Marceglia, Sara, Conti, Costanza, Svanidze, Oleg, Foffani, Guglielmo, Lozano, Andres M, Moro, Elena, Volkmann, Jens, Arlotti, Mattia, Rossi, Lorenzo, Priori, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724732/ https://www.ncbi.nlm.nih.gov/pubmed/34980610 http://dx.doi.org/10.1136/bmjopen-2021-049955 |
Ejemplares similares
-
Eight-hours adaptive deep brain stimulation in patients with Parkinson disease
por: Arlotti, Mattia, et al.
Publicado: (2018) -
The Relationship Between Electrical Energy Delivered by Deep Brain Stimulation and Levodopa-Induced Dyskinesias in Parkinson's Disease: A Retrospective Preliminary Analysis
por: Prenassi, Marco, et al.
Publicado: (2021) -
Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease
por: Bocci, Tommaso, et al.
Publicado: (2021) -
Author Correction: Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease
por: Bocci, Tommaso, et al.
Publicado: (2022) -
Amplitude and frequency modulation of subthalamic beta oscillations jointly encode the dopaminergic state in Parkinson’s disease
por: Averna, Alberto, et al.
Publicado: (2022)